In a 72-year-old woman with type 2 diabetes, severe nausea, vomiting and diarrhea on semaglutide restricted dose escalation.
In plain wordsIn one older woman with type 2 diabetes, severe nausea, vomiting and diarrhea while on semaglutide limited a higher dose.
- Peptide
- Semaglutide
- Outcome
- IncreaseNausea, vomiting and diarrhea limiting dose escalation
- Study
n = 1
- Outcome group
- Gastrointestinal adverse events · Gastrointestinal
- Studied dose
- Dose not stated
Source sentences
Dose escalation was restricted due to severe nausea, vomiting, and diarrhea, which markedly affected her quality of life.
1 context sentence(design, population, supporting numbers)
A 72-year-old woman with a history of cognitive impairment, T2D, atrial fibrillation, obesity, and mood disorders presented with persistent gastrointestinal symptoms while receiving semaglutide.